The Fed’s new, less predictable stance under Kevin Warsh raises the stakes for income investors who rely on dividends as a steady anchor. With rate moves harder to anticipate and inflation pressures still in focus, the gap between fragile payouts and sturdier ones can matter more to a portfolio. This article looks at how the latest Fed signals intersect with defensive dividend stocks, focusing on companies selected for balance sheet strength, moderate risk and controlled payout ratios. Ahead, you will see three stocks from this Defensive Dividend Stocks screener that appear positively exposed to the current policy backdrop.

Metro (TSX:MRU)

Overview: Metro is a Montreal based food and pharmacy retailer that runs supermarkets, discount and neighbourhood grocery stores, and pharmacy banners across Canada, as well as manufacturing a range of private label foods and generic drugs.

Operations: Metro generates about CA$22.2b in revenue from grocery retail in Canada.

Market Cap: CA$19.3b

Metro gives dividend focused investors a way to stay invested in equities while keeping exposure to everyday essentials like food and prescriptions. The company combines a wide store network and growing online channels with steady private label and pharmacy businesses, which can help support cash flows as the Fed signals a tougher line on inflation. At the same time, investors need to weigh high debt levels, margin pressure from labour disputes and competition from discount grocers. With ongoing share buybacks, a confirmed quarterly dividend and an orderly CEO succession plan, Metro offers a mix of resilience and moving parts that may merit closer consideration when deciding how it fits into a defensive income portfolio.

Metro’s mix of essential groceries, pharmacy cash flows and buybacks can appear stronger or more fragile than it first seems, so it is worth lining that story up against the 4 key rewards and 1 important warning sign

Loblaw Companies (TSX:L)

Overview: Loblaw Companies is a large Canadian food and pharmacy retailer that also offers health and beauty products, apparel, general merchandise, financial services and mobile services across banners such as Loblaws, Shoppers Drug Mart, No Frills and Real Canadian Superstore.

Operations: Loblaw generates about CA$64.5b in revenue from its retail operations, all in Canada.

Market Cap: CA$75.1b

Loblaw Companies gives dividend seekers a way to stay in equities through a mix of essential groceries, pharmacies and financial services that can help keep cash flows steadier as the Fed leans more hawkish and less predictable. Earnings growth, a 4.1% net margin and high ROE around 24.6% sit alongside regular buybacks and a recently increased dividend. The PC Optimum ecosystem, clinic expansion and online grocery push show how the company is trying to deepen customer engagement. The flip side is high leverage, political pressure on food pricing, execution risk on big tech and automation projects, and fierce competition from global retailers, which all matter if inflation or rates move against consumer spending.

Loblaw Companies’ mix of essential retail, a 4.1% net margin and 24.6% ROE can look like a straightforward income story, but the bigger question is how durable that engine really is as politics, leverage and tech spending interact with cash returns, which is exactly what the 1 key reward and 1 important warning sign

Quest Diagnostics (DGX)

Overview: Quest Diagnostics is a large US based medical testing provider that runs laboratories, patient service centers and mobile collection services to deliver routine and advanced diagnostics, from blood tests to cancer, neurology and women’s health screening, for doctors, hospitals, health plans, employers, life insurers and consumers.

Operations: Quest Diagnostics generates about US$11.3b in revenue, with roughly US$11.0b from Diagnostic Information Services and US$0.3b from DS Revenues, almost all in the United States.

Market Cap: US$21.6b

Quest Diagnostics sits in a defensive corner of healthcare, combining regular dividends, a large US$11.3b revenue base and exposure to preventive testing, AI enabled lab automation and health data services that can appeal when Fed policy looks less supportive. Q1 2026 results were strong and guidance for 2026 was raised. Yet the stock trades on a lower P/E than many healthcare peers and analysts see room for further earnings growth around 10% a year. The flip side is meaningful debt, reimbursement and policy risk, and a history of weaker earnings trends over 5 years. For income investors watching Kevin Warsh’s tougher stance, the real question is how that mix of resilience and funding risk stacks up against other defensive dividend options.

Earnings at Quest Diagnostics may be quietly decoupling from its P/E and dividend story, which can make the next phase of growth versus funding risk easy to misread. This is exactly what the 4 key rewards and 1 important warning sign

The three stocks covered here are just a starting point, with the full Defensive Dividend Stocks screener surfacing 37 more companies that pair resilient dividends with balance sheet strength and sector diversity. Use Simply Wall St to identify, filter and analyze the exact catalysts, payout profiles and narratives that matter to you, allowing you to focus on the highest conviction defensive income ideas.

Take Control of Your Investment Journey

If Loblaw Companies or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Others Catch On?

Fresh opportunities can move from quiet to crowded fast. Once momentum builds, you may risk chasing instead of leading. Scan these curated stock shortlists while it matters and consider your options.

• Identify under the radar quality before interest broadens by using the 8 high quality undiscovered gems curated for resilient fundamentals and cleaner balance sheets.
• Explore potential income streams that can keep paying through different rate cycles by reviewing the hand picked 6 dividend fortresses built for staying power.
• Review companies linked to critical infrastructure spending trends and grid upgrades by checking the focused 34 power grid technology and infrastructure stocks while many investors are still looking elsewhere.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.